EUVIMEDEUVIMED entdecken
Crossref

Comparison of efficacy of Ketorolac %0.4 and Dexamethasone %0.1 in inflamed Pterygium and Pinguecula

Kaan ÇAKMAK, Safak KORKMAZ, Funda YILMAZ

Interdisciplinary Medical Journal · 2023

DOI: 10.17944/interdiscip.1352006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Interdisciplinary Medical Journal, 2023. Verfasst von Kaan ÇAKMAK und 2 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study investigated the effect of the ketorolac %0.4 and dexamethasone %0.1 on suppressing symptoms in inflamed pterygium and pinguecula.

Methods

50 patients were included in the study. The patients were divided into two groups, each consisting of 25 patients. Ketorolac %0.4 eye drops were dropped in group 1, and dexamethasone %0.1 eye drops were started in group 2. Groups were compared 3,7,14,30,45. days in terms of total signs and symptoms.

Results

After 14 days of drug administration group 1, scores were reduced %85 for total signs (2.52+1.16, p=0.001), %86 for total symptoms (4.10+2.61, p=0.001) and total scores showed a significant reduction of %86 (6.62+2.91, p=0.001) for the score. After 14 days of drug administration in group 2, scores were reduced %85 for total signs (2.70+1.46, p=0.001), %86 for total symptoms (4.25+2.36, p=0.001), and total scores showed a significant reduction of %86 (7.10+2.99, p=0.001) for the score. The scores for each sign and symptom decreased during the study. However, the statistical evaluation of each sign and symptom was similar in groups 1 and 2. There was no difference between groups 1 and 2 for total signs, total symptoms, and total score on days 3,7 and 14. No significant difference was found between groups 1 and 2 for total signs, total symptoms, and total score on days 14,30 and 45 (p>0.05).

Conclusion

Current study revealed that topical ketorolac %0.4 solutions are as effective as dexamethasone in treating inflammatory pterygium and pinguecula. We suggest that it can be used alone to treat this disease. We need more studies to support our work.

Zitieren

APA

ÇAKMAK, K., KORKMAZ, S., & YILMAZ, F. (2023). Comparison of efficacy of Ketorolac %0.4 and Dexamethasone %0.1 in inflamed Pterygium and Pinguecula. Interdisciplinary Medical Journal. https://doi.org/10.17944/interdiscip.1352006

Vancouver

ÇAKMAK K, KORKMAZ S, YILMAZ F. Comparison of efficacy of Ketorolac %0.4 and Dexamethasone %0.1 in inflamed Pterygium and Pinguecula. Interdisciplinary Medical Journal. 2023. doi:10.17944/interdiscip.1352006

BibTeX
@article{AKMAK2023,
  author = {ÇAKMAK, Kaan and KORKMAZ, Safak and YILMAZ, Funda},
  title = {Comparison of efficacy of Ketorolac %0.4 and Dexamethasone %0.1 in inflamed Pterygium and Pinguecula},
  journal = {Interdisciplinary Medical Journal},
  year = {2023},
  doi = {10.17944/interdiscip.1352006}
}
Kostenlos starten →